US Broker Ratings

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: High Growth in Healthcare with 9.49% Upside

Madrigal Pharmaceuticals, Inc. (MDGL) has been capturing the attention of investors looking for promising opportunities in the healthcare sector, specifically within biotechnology. With a market capitalization..

Avantor, Inc. (AVTR) Stock Analysis: Exploring an 18% Potential Upside for Investors

Avantor, Inc. (NYSE: AVTR), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $7.87 billion,..

Teleflex Incorporated (TFX): Investor Outlook Reveals 13.48% Potential Upside Amidst Robust Revenue Growth

Teleflex Incorporated (NYSE: TFX) is a prominent player within the healthcare sector, specifically in the medical instruments and supplies industry. With a market capitalization of $4.83..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Healthcare Innovator with 19% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX) has carved a niche for itself in the healthcare sector, specifically within the medical devices industry. Known for its innovative approach..

Hologic, Inc. (HOLX) Stock Analysis: Navigating a Promising Terrain in Women’s Health with a 2% Potential Upside

Hologic, Inc. (HOLX), a stalwart in the healthcare sector, has carved a formidable niche in the medical instruments and supplies industry. With a market capitalization of..

Moderna, Inc. (MRNA) Investor Outlook: Exploring a Potential 63.61% Upside Amidst Revenue Challenges

Moderna, Inc. (NASDAQ: MRNA), a leader in the biotechnology sector, has been a focal point for investors seeking to understand the evolving landscape of mRNA technology..

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 30% Potential Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH) presents an intriguing opportunity for investors in the healthcare sector, particularly within the niche of over-the-counter (OTC) health and personal..

Ionis Pharmaceuticals, Inc. (IONS): Investor Outlook Highlights 13% Potential Upside Amid Robust Pipeline and Strategic Collaborations

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) has emerged as a formidable player in the biotechnology sector, captivating investor interest with its innovative RNA-targeted medicines. With a market..

Natera, Inc. (NTRA) Stock Analysis: A Healthcare Leader with Strong Growth Potential and a 9.55% Upside

Natera, Inc. (NASDAQ: NTRA) stands out in the healthcare sector as a formidable player in the diagnostics and research industry. With a current market capitalization of..

Bio-Techne Corp (TECH) Stock Analysis: Unpacking a Promising 18.88% Potential Upside

Bio-Techne Corp (NASDAQ: TECH), a notable player in the biotechnology sector, is capturing the attention of investors with its strong growth potential and a promising 18.88%..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A Deep Dive into Its 25.96% Potential Upside

iRhythm Technologies, Inc. (NASDAQ: IRTC) stands out in the healthcare sector, particularly in the medical devices industry, as it continues to capture investor attention with its..

Waters Corporation (WAT) Stock Analysis: A Stable Player with a 4.35% Upside Potential in the Healthcare Sector

Waters Corporation (NYSE: WAT), with a commanding presence in the Healthcare sector’s Diagnostics & Research industry, has been a reliable performer for investors seeking stability and..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring an 11.91% Upside in the Healthcare Sector

The Ensign Group, Inc. (NASDAQ: ENSG) is making waves in the healthcare sector, particularly in the realm of medical care facilities. With a market capitalization of..

Biogen Inc. (BIIB) Investor Outlook: Robust Pipeline and 13.64% Upside Potential

Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector, is generating buzz among investors due to its promising pipeline and significant upside potential. With..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Unlocking Potential with an 88.10% Revenue Growth in Biotechnology

Avidity Biosciences, Inc. (NASDAQ: RNA), a prominent player in the biotechnology sector, is capturing the attention of investors with its intriguing blend of cutting-edge RNA therapeutics..

Bausch + Lomb Corporation (BLCO) Stock Analysis: A Close Look at Its Modest Upside and Strategic Position in the Eye Health Industry

Investors with a keen focus on the healthcare sector, particularly in medical instruments and supplies, may find Bausch + Lomb Corporation (NYSE: BLCO) an intriguing prospect...

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating the Potential Amidst Analyst Caution

Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the healthcare sector, is a company that has carved a niche in the diagnostics and research industry...

ICON plc (ICLR) Stock Analysis: Evaluating a 30% Upside Potential in the Healthcare Sector

The healthcare sector continues to draw significant investor attention, and ICON plc (NASDAQ: ICLR) stands out as a compelling player in the diagnostics and research industry...

Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant with a Strong Return on Equity

Cencora, Inc. (NYSE: COR), previously known as AmerisourceBergen Corporation, stands as a formidable player in the healthcare sector, specifically in medical distribution. With a rich history..

Rhythm Pharmaceuticals (RYTM) Investor Outlook: A Potential 21% Upside in the Biotech Frontier

Rhythm Pharmaceuticals, Inc. (RYTM), a burgeoning player in the biopharmaceutical industry, is garnering significant attention from investors with a potential upside of 21.07%, according to the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds